Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Plos One|April 9, 2019
Live applications of norbormide-based fluorescent probes in Drosophila melanogasterAlessia Forgiarini, Zifei Wang, Claudio D'Amore, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2022
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAsDaniela Gabbia, Sara Carpi, Samantha Sarcognato, et al.
Advanced Healthcare Materials|August 17, 2023
Anti-HER2 Super Stealth Immunoliposomes for Targeted-ChemotherapyElena Canato, Antonella Grigoletto, Ilaria Zanotto, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 8, 2020
Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patientsMaria G Zenti, Maria G Lupo, Sara De Martin, et al.
Frontiers in Nutrition|October 21, 2021
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the LiverDaniela Gabbia, Sara Carpi, Samantha Sarcognato, et al.
International Journal of Molecular Sciences|October 27, 2022
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated SignalingStephen M Stahl, Sara De Martin, Andrea Mattarei, et al.
Journal of Medicinal Chemistry|March 24, 2026
Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2Zhanna Romanyuk, Giacomo Bettin, Paul Brear, et al.
Atherosclerosis|February 9, 2022
PCSK9 promotes arterial medial calcificationMaria Giovanna Lupo, Alessandro Bressan, Maristella Donato, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate ReceptorsEzio Bettini, Stephen M Stahl, Sara De Martin, et al.
British Journal of Pharmacology|July 30, 2017
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile miceValentina Caputi, Ilaria Marsilio, Viviana Filpa, et al.
Pageof 10